logo
logo
AI + EXCLUSIVE DATA

AI tracks executive moves from sources others don't have

Our proprietary AI analyzes exclusive hiring data to find decision-makers actively evaluating solutions like yours.

10-25 executive leads daily • Direct contact info • First 90 days targeting
Start with:
7-day trial • $39/mo or $29/mo annual
AI + proprietary hiring database
Executive contact details included
INDUSTRY FIRST

Applied Stem Cell, Inc. Strengthens Executive Leadership With Two Key Appointments

Dec 04, 2023over 1 year ago

Position

Chief Commercial Officer

Company

Applied StemCell

George Hong
MilpitasGeneticsTherapeuticsBiotechnologyHealth Care

Description

Applied StemCell Inc, a leading CRO/CDMO recognized for its proprietary TARGATT gene editing technology and expertise in stem cells and cell therapy development, is pleased to announce the addition of two accomplished professionals to its C-level executive team: George Hong (Chief Commercial Officer) and Timothy J. Largen (Chief Operating Officer)

Company Information

Company

Applied StemCell

Location

Milpitas, California, United States

About

Advancing Gene and Cell Product Development Through iPSC and Genome Editing Technologies. Applied StemCell strives to advance gene-editing and stem cell innovation for biomedical research and the biotechnology industry to assist in the development of breakthrough therapeutic approaches to cure intractable diseases.

FundzWatch™ Score

89
Medium Activity

Related People

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months